| From nanotechnology to nanomedicine: applications to cancer research. | |
| | |
MedLine Citation:
|
PMID: 20712588 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Scientific advances have significantly improved the practice of medicine by providing objective and quantitative means for exploring the human body and disease states. These innovative technologies have already profoundly improved disease detection, imaging, treatment and patient follow-up. Today's analytical limits are at the nanoscale level (one-billionth of a meter) enabling a detailed exploration at the level of DNA, RNA, proteins and metabolites which are in fact nano-objects. This translational review aims at integrating some recent advances from micro- and nano-technologies with high potential for improving daily oncology practice. |
| | |
Authors:
|
R Seigneuric; L Markey; D S A Nuyten; C Dubernet; C T A Evelo; E Finot; C Garrido |
Related Documents
:
|
16131288 - Medicinal benefits of green tea: part ii. review of anticancer properties. 8871508 - Radiation oncology at the centennial. 16996508 - In vitro maturation of human oocytes for assisted reproduction. 7065958 - Scleral buckling for retinal detachments complicated by periretinal proliferation. 19945698 - B-lynch suture, intrauterine balloon, and endouterine hemostatic suture for the managem... 21040078 - Why do junior doctors not want to work in a rural location, and what would induce them ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Current molecular medicine Volume: 10 ISSN: 1875-5666 ISO Abbreviation: Curr. Mol. Med. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-08-26 Completed Date: 2011-01-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101093076 Medline TA: Curr Mol Med Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 640-52 Citation Subset: IM |
Affiliation:
|
Département Nanosciences, Laboratoire Interdisciplinaire Carnot de Bourgogne, CNRS-UMR 5209, 9, Avenue Alain Savary, BP 47870, 21078 DIJON Cedex, France. renaud.seigneuric@u-bourgogne.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents* Biosensing Techniques* Drug Delivery Systems / methods* Humans Microfluidics Nanomedicine* Nanoparticles Nanotechnology* Neoplasms* / drug therapy, metabolism, pathology Neovascularization, Physiologic Signal Transduction Tumor Markers, Biological |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Tumor Markers, Biological |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hypoxia and fetal heart development.
Next Document: Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.